2.1. Analysis.

Comparison 2 Antifibrinolytic drugs vs placebo or open control, Outcome 1 Death or dependence (mRS 4 to 6) at day 90.

Comparison 2 Antifibrinolytic drugs vs placebo or open control, Outcome 1 Death or dependence (mRS 4 to 6) at day 90.